stars 1 stars 2 stars 3

Echo Pharmaceuticals is an innovative technology-based pharmaceutical company located in the Netherlands. We are known for our first-class experience in extraction, purification, and formulation of lipophilic active compounds, particularly cannabinoids. Using our patented knowledge of drug formulation, we develop the optimized formulation of active pharmaceutical ingredients for clinical investigations and perform clinical trials. Echo Pharmaceuticals’ proprietary knowledge and competences are in extracting and purifying arbitrary APIs from plant materials. Isolation takes place under controlled laboratory conditions, which guarantees the high quality of the purified API. As a result, we produce a wide range of cannabinoid standards for analytical purposes and two cannabinoid APIs, all produced under cGMP guidelines. Echo Pharmaceuticals supplies R&D organizations around the globe.

Echo Pharmaceuticals Questions

The Echo Pharmaceuticals annual revenue was $1 million in 2026.

Anthony Kievid is the Chief Commercial Officer (CCO) of Echo Pharmaceuticals.

17 people are employed at Echo Pharmaceuticals.

Echo Pharmaceuticals is based in Leiden, South Holland.

The NAICS codes for Echo Pharmaceuticals are [32, 3254, 325, 32541].

The SIC codes for Echo Pharmaceuticals are [28, 283].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users